Tramadol, M1 metabolite and enantiomer affinities for cloned human opioid receptors expressed in transfected HN9.10 neuroblastoma cells

European Journal of Pharmacology

Volumn 316, Issue 2-3, 1996, Pages 369-372

  Lai, Josephine ^a   Ma, Shou Wu ^a   Porreca, Frank ^a   Raffa, Robert B ^b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

Analgesia; Cloned human receptor; Opioid receptor type; Tramadol

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DRUG METABOLITE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MORPHINE; NORBINALTORPHIMINE; OPIATE RECEPTOR; TRAMADOL;

ANALGESIA; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL LINE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENANTIOMER; GENE EXPRESSION; MOLECULAR CLONING; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL;

BRAIN NEOPLASMS; HUMANS; NEUROBLASTOMA; RECEPTORS, OPIOID; TRAMADOL;

EID: 0030571489     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00770-4     Document Type: Article

References (13)

1. 50) of an enzymatic reaction, Biochem. Pharmacol. 22, 3099.
2. Collart, L., C. Luthy and P. Dayer, 1994, (±)-Tramadol concentration-effect relationship, Clin. Pharmacol. Ther. 55, 208.
3. 1b subtype, NeuroReport 5, 2161.
4. Lee, C.R., D. McTavish and E.M. Sorkin, 1993, Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states, Drugs 46, 313.
5. Lee, H.J., D.N. Hammond, T.H. Large, J.D. Roback, J.A. Sim, D.A. Brown, U.H. Otten an B.H. Wainer, 1990, Neuronal properties and trophic activities of immortalized hippocampal cells from embryonic and young adult mice, J. Neurosci. 10, 1779.
6. Lowry, O.H., N.J. Rosenbrough, A.L. Farr and R.J. Randall, 1951, Protein measurement with Polin phenol reagent, J. Biol. Chem. 193, 265.
7. Mansson, E., L. Bare and D.M. Yang, 1994, Isolation of a human κ opioid receptor cDNA from placenta, Biochem. Biophys. Res. Commun. 202, 1431.
8. Raffa, R.B., E. Friderichs, W. Reimann, R.P. Shank, E.E. Codd and J.L. Vaught, J.L., 1992, Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J. Pharmacol. Exp. Ther. 260, 275.
9. Raffa, R.B., E. Friderichs, W. Reimann, R.P. Shank, E.E. Codd, J.L. Vaught, H.I. Jacoby and N. Selve, 1993, Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol, J. Pharmacol. Exp. Ther. 267, 331.
10. Raffa, R.B., R.K. Nayak, S, Liao and F.L. Minn, 1995, The mechanism(s) of action and pharmacokinetics of tramadol hydrochloride, Rev. Contemp. Pharmacother. 6, 485.
11. Raynor, K., H.Y. Kong, A. Mestek, L.S. Bye, M.T. Tian, J. Liu, L. Yu and T. Reisine, 1995, Characterization of the cloned human mu opioid receptor, J. Pharnacol. Exp. Ther, 272, 423.
12. Simonin, F., K. Befort, C. Gaveriaux-Ruff, H. Matthes, V. Nappey, B. Lannes, G. Micheletti and B. Kieffer, 1994, The human δ opioid receptor: genomic organization, cDNA cloning, functional expression and distribution in human brain, Mol. Pharmacol. 46, 1015.
13. Simonin, F., C. Gaveriaux-Ruff, K. Befort, H. Matthes, B. Lannes, G. Micheletti, M.G. Mattei, G. Charron, B. Bloch and B. Kieffer, 1995, Kappa-opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system, Proc. Natl. Acad. Sci. USA 92, 7006.